Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes-Reference-Cited by-同舟云学术

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes

Published:2015-11-17 Issue:4 Volume:33 Page:497-505
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Franek E.¹,Haluzík M.²,Canecki Varžić S.³,Sargin M.⁴,Macura S.⁵,Zacho J.⁵,Christiansen J. S.⁶

Affiliation:

1. Mossakowski Medical Research Centre; Polish Academy of Sciences and Department of Internal Diseases, Endocrinology and Diabetology; Central Clinical Hospital MSW; Warsaw Poland

2. Third Department of Medicine; First Faculty of Medicine and General University Hospital; Charles University; Prague Czech Republic

3. Clinical Hospital Center Osijek; Osijek Croatia

4. Kartal Training and Research Hospital; Istanbul Turkey

5. Novo Nordisk A/S; Søborg Denmark

6. Aarhus University Hospital; Aarhus Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12982/fullpdf

Reference23 articles.

1. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town;Haque;S Afr Med J,2005

4. Correlates of insulin injection omission;Peyrot;Diabetes Care,2010

5. Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues;Vaag;Eur J Endocrinol,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2024-09-30

2. Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study;Journal of Family Medicine and Primary Care;2024-09

3. Initiating or switching to insulin degludec/insulin aspart in a real‐world population of adults with type 2 diabetes in Australia: results from a prospective, non‐interventional study;Internal Medicine Journal;2024-08-22

4. Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines;Journal of the ASEAN Federation of Endocrine Societies;2024-08-04

5. Improvement in Glycemic Indices and Point in Range by Addition or Switch to IDegAsp–Real-World Evidence;Journal of Diabetology;2024-07